The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Christensen Jamie since 2014.
This trader's CIK number is 1599324.
At the time of last reporting, Christensen Jamie was the EVP & Chief Scientific Officer of Mirati Therapeutics, Inc.. (stock ticker symbol MRTX).
Also see all insider trading activities at Mirati Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | MRTX | 0 | $0 | 3,128 | $184,292 | 0 | $0 |
| 2023 | MRTX | 0 | $0 | 7,639 | $345,514 | 0 | $0 |
| 2022 | MRTX | 0 | $0 | 6,829 | $587,514 | 0 | $0 |
| 2021 | MRTX | 0 | $0 | 2,660 | $468,678 | 0 | $0 |
| 2020 | MRTX | 0 | $0 | 0 | $0 | 18,937 | $250,708 |
| 2019 | MRTX | 0 | $0 | 6,666 | $833,250 | 6,666 | $36,329 |
| 2018 | MRTX | 0 | $0 | 93,246 | $2,872,128 | 98,190 | $1,547,862 |
| 2017 | MRTX | 0 | $0 | 22,544 | $355,176 | 21,499 | $160,244 |
| 2015 | MRTX | 0 | $0 | 15,500 | $395,730 | 14,250 | $163,447 |
| 2014 | MRTX | 0 | $0 | 0 | $0 | 2,500 | $21,250 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-16 | MRTX | Sale | 1,597 | 59.02 | 94,254 |
| 2024-01-04 | MRTX | Sale | 1,531 | 58.81 | 90,038 |
| 2023-12-18 | MRTX | Sale | 2,387 | 57.50 | 137,252 |
| 2023-09-08 | MRTX | Sale | 2,388 | 35.63 | 85,084 |
| 2023-05-24 | MRTX | Sale | 619 | 45.29 | 28,035 |
| 2023-01-17 | MRTX | Sale | 2,245 | 42.38 | 95,143 |
| 2022-12-16 | MRTX | Sale | 2,410 | 43.00 | 103,625 |
| 2022-12-02 | MRTX | Sale | 1,726 | 90.19 | 155,666 |
| 2022-05-23 | MRTX | Sale | 624 | 63.54 | 39,648 |
| 2022-01-18 | MRTX | Sale | 627 | 120.51 | 75,557 |
| 2022-01-04 | MRTX | Sale | 1,442 | 147.72 | 213,018 |
| 2021-12-06 | MRTX | Sale | 1,201 | 131.39 | 157,799 |
| 2021-01-06 | MRTX | Sale | 1,459 | 213.08 | 310,879 |
| 2020-11-02 | MRTX | Option Ex | 10,879 | 11.96 | 130,145 |
| 2020-03-26 | MRTX | Option Ex | 8,058 | 14.96 | 120,563 |
| 2019-12-23 | MRTX | Sale | 6,666 | 125.00 | 833,250 |
| 2019-12-23 | MRTX | Option Ex | 6,666 | 5.45 | 36,329 |
| 2018-12-26 | MRTX | Option Ex | 5,169 | 17.41 | 89,992 |
| 2018-06-26 | MRTX | Option Ex | 5,208 | 5.40 | 28,123 |
| 2018-06-27 | MRTX | Option Ex | 4,999 | 5.50 | 27,494 |
| 2018-06-26 | MRTX | Sale | 5,208 | 48.95 | 254,905 |
| 2018-06-27 | MRTX | Sale | 4,999 | 50.30 | 251,449 |
| 2018-03-09 | MRTX | Sale | 22,000 | 33.00 | 726,044 |
| 2018-03-09 | MRTX | Option Ex | 22,000 | 21.30 | 468,666 |
| 2018-02-06 | MRTX | Option Ex | 23,000 | 21.30 | 489,969 |
| 2018-02-06 | MRTX | Sale | 23,000 | 30.00 | 690,000 |
| 2018-01-26 | MRTX | Option Ex | 12,500 | 5.40 | 67,500 |
| 2018-01-26 | MRTX | Sale | 12,500 | 26.11 | 326,425 |
| 2018-01-16 | MRTX | Sale | 10,814 | 27.00 | 291,978 |
| 2018-01-16 | MRTX | Option Ex | 10,814 | 17.41 | 188,271 |
| 2018-01-11 | MRTX | Sale | 14,725 | 22.50 | 331,327 |
| 2018-01-11 | MRTX | Option Ex | 14,500 | 12.96 | 187,847 |
| 2017-11-16 | MRTX | Option Ex | 10,000 | 8.50 | 85,000 |
| 2017-11-16 | MRTX | Sale | 10,275 | 18.00 | 184,950 |
| 2017-11-02 | MRTX | Sale | 7,499 | 14.00 | 104,986 |
| 2017-11-02 | MRTX | Option Ex | 7,499 | 5.50 | 41,244 |
| 2017-10-04 | MRTX | Option Ex | 4,000 | 8.50 | 34,000 |
| 2017-10-04 | MRTX | Sale | 4,000 | 14.00 | 56,000 |
| 2017-09-15 | MRTX | Sale | 770 | 12.00 | 9,240 |
| 2015-05-26 | MRTX | Option Ex | 4,750 | 17.41 | 82,697 |
| 2015-05-26 | MRTX | Sale | 4,750 | 28.07 | 133,337 |
| 2015-03-05 | MRTX | Sale | 6,000 | 25.59 | 153,570 |
| 2015-03-05 | MRTX | Option Ex | 6,000 | 8.50 | 51,000 |
| 2015-02-17 | MRTX | Option Ex | 400 | 8.50 | 3,400 |
| 2015-02-17 | MRTX | Sale | 1,650 | 22.70 | 37,446 |
| 2015-02-19 | MRTX | Option Ex | 3,100 | 8.50 | 26,350 |
| 2015-02-19 | MRTX | Sale | 3,100 | 23.02 | 71,377 |
| 2014-12-05 | MRTX | Option Ex | 2,500 | 8.50 | 21,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Christensen Jamie (EVP & Chief Scientific Officer of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.